Access Bio, Others Hit Back At $1B 'Windfall' Virus Test Suit
Access Bio Inc. and two other medical companies hit back at Intrivo Diagnostics Inc.'s latest lawsuit accusing them of reneging on a deal to make COVID-19 tests, saying on Thursday that Intrivo is seeking a "windfall judgment" of $1 billion without the facts to back up its claims.
Source: law360.com